Mode
Text Size
Log in / Sign up
N/A Completed N=300 Randomized Single-blind Treatment

LOGIC-Insulin Algorithm-guided Versus Nurse-directed Blood Glucose Control During Critical Illness

Source: ClinicalTrials.gov NCT01420302 ↗
Enrolled (actual)
300
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Glycemic Penalty Index (GPI) During the Intervention — 9.8; 12.4 units on a scale — p=<0.0001

Summary

The LOGIC-Insulin computerized software algorithm will be compared with a nurse-directed protocol, both targeting a blood glucose level of 80-110 mg/dL, in critically ill patients

Outcome Measures

OutcomeResultp-value
PRIMARY
Glycemic Penalty Index (GPI) During the Intervention
9.8; 12.4 <0.0001 sig
SECONDARY
Proportion of Patients With Severe Hypoglycemia (<40 mg/dL) During the Intervention
— —
SECONDARY
Incidence of Severe Hypoglycemia (<40 mg/dL) During the Intervention
— —
SECONDARY
Blood Glucose Level Per Treatment Group During the Intervention
— —
SECONDARY
Hyperglycemic Index (HGI) During the Intervention
— —
SECONDARY
Daily Maximal Blood Glucose Difference During the Intervention
— —
SECONDARY
Proportion of Patients With Common Hypoglycemia (<60 mg/dL) During the Intervention
— —
SECONDARY
Interval Between Blood Glucose Measurements During the Intervention
— —
SECONDARY
Percentage of Time in Target Zone (80-110 mg/dL) During the Intervention
— —
SECONDARY
Length of Stay in ICU
— —
SECONDARY
Length of Stay in Hospital
— —
SECONDARY
Hospital Mortality
— —
SECONDARY
Incidence of Common Hypoglycemia (<60 mg/dL) During the Intervention
— —

Eligibility Criteria

Inclusion Criteria

  • Aged 18 years or more
  • Admitted to the ICU
  • Already receiving or needing insulin infusion for blood glucose control

Exclusion Criteria

  • Not critically ill (eating, not mechanically ventilated)
  • Pregnant or breastfeeding
  • Previous inclusion into the trial
  • Included in other trial
  • Moribund
  • Diabetes coma
  • No arterial line available
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01420302). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search